HHMI News
  Top Stories  
dashed line
Research News
dashed line

Tick Saliva: New Target for Lyme Disease Vaccinesmall arrow

dashed line

High Blood Pressure During Pregnancy May Set Stage for Thyroid Problems Latersmall arrow

dashed line

Teasing Apart Brain Function, Neuron by Neuronsmall arrow

dashed line

Moresmall arrow

dashed line
  Science Education News  
dashed line
  Institute News  
dashed line
  NewsSrch  
dashed line
  Noticias  

FOR FURTHER
INFORMATION:


Jennifer Michalowski
(301) 215-8576
michalow@hhmi.org
dashed line Jim Keeley
(301) 215-8858
keeleyj@hhmi.org
dashed line Howard Hughes
Medical Institute
4000 Jones Bridge Road Chevy Chase, MD 20815-6789
(301) 215-8500


News Alert
Sign Up
Research News

February 13, 2008
Cell Silences Genes on the Nuclear Edge

A highly magnified mouse cell nucleus, showing the location of a fluorescently labeled gene (green/yellow). HHMI researchers developed a unique molecular tool that dragged this gene from the center of the nucleus to the membrane, deactivating it in the process. Their findings demonstrate that the precise location of a gene within the nucleus is important to its functioning.

In the cell's nucleus, neighborhoods matter. By corralling certain genes at the edge of the nucleus, developing immune cells can control a gene's activity and keep it switched off, according to a new study from Howard Hughes Medical Institute (HHMI) researchers.

The finding comes as the result of researchers' efforts to understand how blood stem cells mature into the various types of immune system cells that recognize invading bacteria and viruses. Senior author Harinder Singh, an HHMI investigator at the University of Chicago, and his colleagues reported their finding February 13, 2008, in an advance online publication of the journal Nature.


“What we have been able to show is that location or neighborhood of a gene within the nucleus actually matters in terms of its activity.”
Harinder Singh

The human immune system relies on several types of cells to recognize foreign invaders so that the body can destroy them. Two of these, known as B cells and T cells, can recognize myriad invaders and help coordinate a customized immune response. Receptors that stud the surfaces of B and T cells aid this recognition process by binding to antigen molecules on the surface of the invading pathogen. In B cells these receptors are called antibodies; T cells have different structures called T cell receptors.

HHMI Media
media image Audio Interview with Harinder Singh
Harinder Singh discusses his recent research on immune cell development.
Run time: 5 minutes.
Play Audiosmall arrow


Interviewed by Benjamin Lester/HHMI

Both B cells and T cells mature from blood stem cells, and use the same set of proteins to organize activation of their receptor genes. But the set of genes that encodes B cell antibodies is different from the set of genes that encodes T cell receptors. One main question has intrigued Singh: Given their developmental similarities, how do B and T cells avoid turning on the wrong genes?

Singh's previous work suggested that nuclear neighborhoods might provide part of the answer. In blood stem cells, the gene segments that encode both antibodies and T cell receptors are attached to the inside of the nuclear membrane. Singh's group had found “that the antibody genes were being moved [toward the center of] the nucleus in B cells as they developed,” said Singh. In developing T cells, on the other hand, those same gene segments—which are never switched on—remained stuck to the membrane.

Singh wondered if this organization created miniscule nuclear neighborhoods whose genetic occupants could not be activated. If so, Singh reasoned that developing T cells might leave the unneeded antibody genes pinned against the nuclear membrane to avoid the potential for mistakes. To test the idea, he said, “We needed to develop a method where we could move a gene—any gene—within the nucleus.”

Their goal was to put a gene on the outskirts of the nucleus, next to the nuclear membrane. And in the experiments reported in Nature, Singh, his postdoctoral fellow Karen Reddy, and their colleagues tricked mouse cells into doing just that. The team attached a binding site for the protein LacI to a gene that makes a cell resistant to the cell-killing drug hygromycin, and inserted the assembly into a mouse cell. The team chose the hygromycin resistance gene because it provided any easy way to test gene activity; when exposed to the drug, only cells with an active gene would survive.

In the same cells, they also activated LacI, which dutifully latched on. But in a bit of scientific trickery, the researchers first fused LacI to two other proteins. The first was green fluorescent protein (GFP), which glows brightly and allowed the team to identify the assembly's location. The second was a protein called emerin, which normally resides in the nuclear membrane. Regardless of the other proteins and DNA that the researchers had attached to it, the cell recognized that emerin belonged in the membrane, and dragged it there, Singh explained. When it did, the attached test gene stopped functioning, as did neighboring genes.

“What we have been able to show is that location or neighborhood of a gene within the nucleus actually matters in terms of its activity,” said Singh. “It's evidence. . . that this sort of repositioning has consequences.”

Besides answering why developing immune cells sequester genes at the edge of their nuclei, Singh said the study opens intriguing new avenues for research. According to Singh, the mechanism only works in cells that are still dividing. “When we block cells from dividing, we cannot drag these genes to the inner nuclear membrane,” he said. Singh thinks these nuclear neighborhoods might help specialized cells in the muscles, nerves, and organs customize which genes they express as they develop from non-specific stem cells. “We think that this sort of mechanism might be used quite widely” in the body, he said.

Singh also said that the mechanism might one day be used in treating diseases caused by malfunctioning genes. With a better understanding of the molecular mechanism that cells use to position genes, Singh said, scientists may begin to be able to develop drugs that take advantage of this process, he said. “In the context of cancerous cells, if you want to turn genes off that are inappropriately active and driving that cancer,” one way to do it might be to drag them to the nuclear membrane. “However,” he said, “I think [such treatments are] quite a ways away.”

Image: Karen L. Reddy

   

MORE HEADLINES

bullet icon

INSTITUTE NEWS

11.17.09 | 

Grants Push Grad Schools to Bring Research and Medicine Together

10.12.09 | 

HHMI Scientists Elected to Institute of Medicine

09.28.09 | 

Jeffrey Friedman to Receive Keio Medical Science Prize
Noticias del HHMI Search News Archive

Download Story PDF

Requires Adobe Acrobat

HHMI INVESTIGATOR

Harinder  Singh
Harinder Singh
abstract:
Gene Regulatory Networks Orchestrating Cell Fates in the Immune and Hematopoietic Systems
 

Related Links

AT HHMI

bullet icon

Targeting the Sex Chromosome for Repression
(11.27.06)

bullet icon

Immune System Switch Controls Destiny of White Blood Cells
(05.25.00)

bullet icon

Structural Biology Reveals How T Cells Recognize Transplanted Tissue
(04.05.07)

dashed line
 Back to Topto the top
© 2009 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | email: webmaster@hhmi.org